Search results for " acquisition" in Articles / App Notes
Article
Next Generation Process Chromatography
Seven years later, Cytiva would bring Fibro to the market following the acquisition of Puridify in 2017.
Fibro is a new chromatography platform that enables the purification of therapeutic antibod…
Article
Improving Upstream Predictability
Pall’s mPath platform features supervisory control and data acquisition capabilities that allow users to handle process control, monitoring, and data logging. Pall has also developed modeling and scal…
Article
Science Focus Fuels Successful Process Development for Startups
“Ideas are more easily discussed with the decision makers, and changes in the strategy, acquisition, and development of novel therapies can be implemented more rapidly at smaller firms. Additionally, …
Article
Automating the Biomanufacturing Process
Smart modular data integration packages can be integrated easily and quickly into distributed control system (DCS) and supervisory control and data acquisition (SCADA) systems. This enables faster bui…
Article
An Analytical Approach to Biosimilar Drug Development
In addition, these analytical tools are required to be more accessible and automated to conduct acquisition, processing, and reporting from characterization and comparability studies that are needed f…
Article
Cytiva Opens Biotechnology Manufacturing Center in UK
GE Healthcare Opens Biotechnology Manufacturing Center in UK
Cytiva is opening a biotechnology manufacturing center at the Stevenage Bioscience Catalyst (SBC) Open Innovation Campus, in Stevenage…
Article
Using Multiple Techniques in Biosimilar Analysis
Buffer-subtracted spectra were generated by acquiring a background measurement of the formulation buffer immediately prior to spectrum acquisition for each sample. At all temperatures investigated, th…
Article
A Plastic Pipeline for Commercial Bioprocessing?
Thermo Fisher Scientific’s acquisition of Patheon in 2017 created a unique equipment supplier-drug product manufacturer relationship. Hughes says, however, that Patheon is flexible and will not force …
Article
Innovation vs. Capacity: How CMOs Compete
The strategies of an innovation-driven CMO may be different than a capacity-driven CMO.
By Jim Miller
While industry participants and observers talk about the “CMO industry,” they know that …
Article
Biopharma in 2015: A Year for Approvals and Innovations
Immediately following its acquisition by Pfizer, Hospira announced a major milestone in February, 2015: its first monoclonal antibody (mAb) biosimilar was approved for use in West Europe.2 And in Nove…